Exercise Training in Transthyretin Cardiac Amyloidosis

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Brigham and Women's Hospital
Study ID
NCT05797857
Status
Recruiting
Apply to this trial

Conditions

  • Amyloid Cardiomyopathy
  • Transthyretin Cardiac Amyloidosis

Eligibility Criteria

Sex
ALL
Age
60 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Exercise Training — OTHER
    A supervised, personalized exercise training program, which will consist of two 60-minute exercise training sessions per week.

Study Details

Transthyretin cardiac amyloidosis causes debilitating heart failure in older adults. The proposed research will develop a personalized exercise training program to improve functional capacity in patients on optimal treatment for transthyretin cardiac amyloidosis. This is a vital next step to improve functional capacity and quality of life of people suffering from transthyretin cardiac amyloidosis.

Key Dates

Start date
Jul 10, 2024
Status verified
Mar 2025
Primary completion
Jun 30, 2029
Completion
Jun 30, 2030

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention arm

Primary Outcome Measure

peak oxygen consumption (VO2) [ Time Frame: 12 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Brigham and Women's HospitalBostonMassachusetts02115
Sarah Cuddy, MD
[email protected]
6177328410

Find similar trials in Boston, MA

By research site
Brigham and Women's Hospital· Boston, MA

Related Studies